What Are the Real Risks of Tirzepatide?

What side effects do most people on tirzepatide actually experience?

The side effects that show up most often in clinical trials and in real-world use are firmly in the digestive category. Nausea tops the list, followed by diarrhoea, constipation, indigestion, acid reflux and burping. Fatigue, headache and dizziness are reported less often but are not rare. A fuller breakdown of tirzepatide side effects shows that these reactions tend to be most noticeable after starting treatment or stepping up to a higher dose, and for many people they settle within a week or two as the body adjusts.

Injection-site reactions (redness, mild swelling, a little tenderness) happen in a smaller proportion of people and are generally short-lived. Rotating the injection site between the abdomen, thigh and upper arm helps reduce them. The NHS tirzepatide information page covers the full side-effect profile in plain language and is worth reading alongside the Patient Information Leaflet that comes with your pen.

None of this is comfortable reading. But the same trial data that records these effects also shows that the majority of participants completed 72 weeks of treatment — which tells you something about tolerability over time. That said, individual responses vary, and what one person barely notices another may find hard to push through. That is why dose titration exists: the starting dose is deliberately low to give the body time to adapt, not to produce results straight away.

Which tirzepatide risks are serious and how common are they?

Serious adverse events are less common but real, and the evidence on tirzepatide risks and side effects is clear enough that they appear in the Summary of Product Characteristics and in MHRA communications.

Acute pancreatitis is the most discussed. In January 2026, the MHRA issued a Drug Safety Update specifically addressing GLP-1 medicines and pancreatitis, confirming it as a known and potentially serious risk. It is infrequent (the absolute numbers in trials are low) but the consequence if it occurs is significant. Anyone with a personal or family history of pancreatitis should raise this explicitly during their consultation, as it is one of the factors a prescriber weighs carefully.

Gallbladder problems, including gallstones and gallbladder inflammation, are also noted in the prescribing information. Rapid weight loss itself increases gallstone risk, so this is partly a consequence of the treatment working rather than the medicine alone. The longer-term risk picture for tirzepatide covers this in more depth.

Dehydration and related kidney strain can follow severe or prolonged vomiting and diarrhoea. This is not a direct effect of the medicine but a consequence of fluid loss, staying well hydrated, especially during the adjustment period, matters. People taking certain blood pressure medicines or diuretics should flag this to their prescriber.

There is also a theoretical concern about medullary thyroid carcinoma based on animal studies, which is why a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 is a contraindication in the prescribing information.

When does a tirzepatide side effect need urgent medical attention?

This is a question our prescribers hear most weeks, usually from people who are not sure whether what they're feeling is a normal adjustment reaction or something that needs a call to 111 or a trip to A&E. The distinction matters.

Get medical help the same day or call 999 if you experience: severe stomach pain that spreads to the back, with or without vomiting (this combination is a classic presentation of pancreatitis and should not be waited out); signs of a serious allergic reaction, including swelling of the face, lips, mouth or throat, difficulty swallowing or breathing, or a widespread rash; symptoms of gallbladder trouble, such as sudden severe pain in the upper right abdomen, especially with fever or jaundice; or signs of serious dehydration (not passing urine, confusion, extreme dizziness) following a bout of vomiting or diarrhoea that has not settled.

Mental health changes, including low mood, depressive episodes or thoughts of self-harm, should also prompt a conversation with a doctor. This link is under active review across the GLP-1 class, though no causal relationship has been established. If you notice a shift in mood that feels out of character, tell your GP.

For anything that feels concerning but not immediately dangerous, our support team is available seven days a week and can triage whether your prescriber needs to be involved. Do not wait for your next scheduled review if something does not feel right.

Are there people for whom the risks of tirzepatide outweigh the benefits?

Yes, and identifying them is exactly what the clinical assessment is for. Tirzepatide is not licensed for use in pregnancy, during breastfeeding, or for people who are actively trying to conceive, if pregnancy is possible, effective contraception is required, and women using oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be affected. This is set out in NHS England's guidance on weight-management injections.

The medicine is not licensed for under-18s. People with a history of medullary thyroid carcinoma or MEN2 should not take it. Certain gastrointestinal conditions, current or recent pancreatitis, and particular combinations of other medicines are also factors that a prescriber must weigh individually.

The Mounjaro risks page covers the brand-specific contraindication list alongside practical guidance on managing the more common effects, and our dedicated page on Mounjaro side effects goes further into what patients actually report day to day, including the sulphur burps that many people on tirzepatide find surprisingly persistent. If you are considering treatment and have a complex medical history, the honest route is a full clinical consultation before anything else. At nume, a GPhC-registered prescriber reads every consultation personally, it is never passed through an automated system. You can learn more about our clinical team or start a free consultation to discuss whether tirzepatide is right for you.